| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B |
| Cost of Revenue | $0.7B | $0.6B | $0.6B | $0.7B | $0.5B | $0.5B | $0.5B | $0.5B |
| Gross Profit | $2.1B | $2.1B | $2.1B | $2.0B | $1.8B | $1.6B | $1.5B | $1.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B |
| Operating Income | $0.3B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Net Income | $0.4B | $0.2B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $3.48 | $1.61 | $1.01 | $0.96 | $0.45 | $0.96 | $0.60 | $0.50 |
| EPS (Diluted) | $3.47 | $1.61 | $1.01 | $0.94 | $0.44 | $0.94 | $0.59 | $0.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.6B | $11.4B | $10.2B | $10.6B | $9.8B | $9.2B | $9.8B | $7.2B |
| Current Assets | $0.8B | $2.0B | $0.5B | $0.5B | $0.6B | $0.5B | $0.3B | $0.4B |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.1B | $0.4B | $0.3B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.7B | $1.8B | $1.4B | $0.7B | $0.6B | $0.6B | $1.0B | $1.2B |
| Stockholders' Equity | $-4.9B | $-5.1B | $-5.2B | $-5.3B | $-5.3B | $-4.8B | $-3.7B | $-3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.3B | $1.5B | $1.3B | $1.2B | $1.1B | $1.0B | $0.9B |
| Investing Cash Flow | $-0.6B | $-0.8B | $-0.5B | $-1.4B | $-1.4B | $-0.4B | $-0.9B | $-0.6B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-1.7B | $0.6B | $-1.0B | $-0.1B | $0.3B | $-0.5B | $-0.1B | $-0.1B |